GLOBAL DIABETES DRUGS MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023

Jun 2018 149

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Diabetes is a condition that keeps your body from making enough insulin. Insulin is a hormone that’s made by an organ called the pancreas. When the body doesn’t make enough insulin, sugar builds up in the blood instead of moving to cells and being used for energy. This causes blood sugar to be high. If blood sugar stays high for a long time, it can cause serious health problems – including blindness, kidney damage, heart disease and stroke. That’s why it’s important to take medicine that helps lower blood sugar levels. Diabetes can be managed so you can live a normal, healthy life.
All diabetes drugs work to lower the levels of sugar in the blood. There are two basic types of diabetes drugs: pills by mouth and shots injected into the skin. More than one drug is often needed to manage diabetes. Some people try different pills, take more than one pill, or take a pill along with shots.


Scope of the Report:
This report focuses on the Diabetes Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
As World overall economic downward trend in the past few years, and international economic situation is complicated, in the next few years there will be many uncertainties, coupled with diabetes drug industry in short supply on the market in the past few years, more companies will enter into the diabetes drug industry, the current demand for diabetes drug product is relatively high; comparing to the ordinary diabetes drug products selling on the market. Diabetes drug’s price remains in the same level as compared with the past years. The signal of market price change indicates the trend in the diabetes drug industry, the market still have large potential.
The worldwide market for Diabetes Drugs is expected to grow at a CAGR of roughly 5.4% over the next five years, will reach 77900 million US$ in 2023, from 57000 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
- Sanofi
- Novo Nordisk
- MSD
- Astrazeneca
- Takeda
- Novartis
- North China Pharmaceutical Group Corporation
- Huadong Medicine
- Dongbao Pharmaceutical Co.,LTD
- Hisun Pharmacy
- KELUN
- Ginwa
- Tianan Pharmaceutical
- Jumpcan Pharmacy
- Guangzhou Baiyun Mountain
- SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD
- Wanbang Biopharmaceuticals
- Gan & Lee
- Taloph

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Sulphonylureas
- Biguanides
- Meglitinides
- Thiazolidinediones
- Alpha-glucosidase Inhibitors
- DPP-4 Inhibitors
- SGLT-2 Inhibitors

Market Segment by Applications, can be divided into

There are 15 Chapters to deeply display the global Diabetes Drugs market.
Chapter 1, to describe Diabetes Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Diabetes Drugs, with sales, revenue, and price of Diabetes Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Diabetes Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Diabetes Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Diabetes Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(May 19)

Scope of the Report: The worldwide market for Tiamulin is expected to grow at a CAGR of roughly over the next five years, will reach ...

(May 19)

Scope of the Report: The worldwide market for Small Molecule Active Pharmaceutical Ingredient is expected to grow at a CAGR of roughl...

(May 19)

Scope of the Report: The global Small Molecule Targeted Cancer Therapy market is valued at million USD in 2018 and is expected to rea...

(May 19)

Scope of the Report: The worldwide market for Oral Solid Dosage Pharmaceutical Formulation is expected to grow at a CAGR of roughly o...

(May 19)

Scope of the Report: The worldwide market for Veterinary Clostridium Vaccines is expected to grow at a CAGR of roughly over the next ...

(May 19)

Scope of the Report: The worldwide market for Clinical Nutrition is expected to grow at a CAGR of roughly over the next five years, w...

GLOBAL DIABETES DRUGS MARKET 2018 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use MAY15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy